Recordati Rare Diseases

• Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.

  Collaborator, Phase 1/2, Not yet recruiting, 89 people, 1 Oct 2026

Sources: clinicaltrials.gov

• Impact of Age, Sex, and Race on Primary Aldosteronism Test Interpretations

  Consulting or advice, Fees or honoraria, 10 Dec 2025

• Towards a reference cell atlas of liver diversity over the human lifespan

  Consulting or advice, 13 Oct 2025

Sources: pubmed.ncbi.nlm.nih.gov